In conclusion, our data show that elevated CEBPA binding to the G2DHE, driven by the hypermorphic effect of CebpaNT, increases TET2-mediated demethylation of the Gata2 promoter, which leads to elevated Gata2 levels in CebpaDM AML. The gene discussed is TET2; the disease is acute myeloid leukemia.